Hemorrhagic stroke and anticoagulation in COVID-19
- 1 August 2020
- journal article
- research article
- Published by Elsevier BV in Journal Of Stroke & Cerebrovascular Diseases
- Vol. 29 (8), 104984
- https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104984
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- COVID-19 and intracerebral haemorrhage: causative or coincidental?New Microbes and New Infections, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight PatientsPlasmatology, 2019
- Imaging of Intracranial HemorrhageJournal of Stroke, 2017
- Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral AnticoagulantsJAMA Neurology, 2016
- Warfarin-associated Intracerebral Hemorrhage is Increasing in Prevalence in the United StatesJournal Of Stroke & Cerebrovascular Diseases, 2013
- Anticoagulants: A Review of the Pharmacology, Dosing, and ComplicationsCurrent Emergency and Hospital Medicine Reports, 2013
- The ICH ScoreStroke, 2001
- Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen ActivatorStroke, 2001